Previous close | 40.90 |
Open | 41.34 |
Bid | 40.54 x 200 |
Ask | 40.79 x 300 |
Day's range | 40.61 - 41.34 |
52-week range | 36.12 - 51.04 |
Volume | |
Avg. volume | 51,559 |
Market cap | 514.293M |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | 30.08 |
EPS (TTM) | 1.35 |
Earnings date | 02 May 2024 |
Forward dividend & yield | 0.15 (0.37%) |
Ex-dividend date | 21 Dec 2023 |
1y target est | 62.50 |
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register.vevent.com/
IRADIMED (NASDAQ:IRMD) has had a rough three months with its share price down 7.0%. But if you pay close attention, you...